Delcath Phase 3 Trial Results To Be Published In Annals Of Surgical Oncology
October 14, 2015 at 08:03 AM EDT
Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the ...
